GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Impax Laboratories, Inc. (IPXL) [hlAlert]

Rating:
Buy IPXL
up 63.57 %

Impax Laboratories, Inc. (IPXL) upgraded to Buy with price target $37 by Needham

Posted on: Friday,  Oct 10, 2014  8:25 AM ET by Needham

Needham rated Buy Impax Laboratories, Inc. (NASDAQ: IPXL) on 10/10/2014, when the stock price was $26.88. Since
then, Impax Laboratories, Inc. has gained 63.58% as of 01/20/2016's recent price of $43.97.
If you would have followed this Needham's recommendation on IPXL, you would have gained 63.57% of your investment in 467 days.

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company. The Company is focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development and formulation expertise. In the generic pharmaceuticals market, the Company focuses its efforts on controlled-release generic versions of selected brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals market, Impax is developing products for the treatment of central nervous system (CNS), disorders. Its brand-name product portfolio consists of development-stage projects to which it is applying its formulation and development expertise to develop differentiated, modified, or controlled-release versions of marketed drug substances. The Company operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceutical Division (Impax Division).

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/10/2014 8:25 AM Buy
None
26.88 37.00
as of 10/17/2014
1 Week down  -0.63 %
1 Month down  -0.63 %
3 Months down  -0.63 %
1 YTD down  -0.63 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/23/2010 8:25 AM Hold
None
17.60

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy